End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,84,500 KRW | -0.52% | +9.63% | +188.83% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+188.83% | 1.09TCr | |
+2.99% | 9.48TCr | |
-3.68% | 3.76TCr | |
-9.88% | 3.33TCr | |
+75.48% | 2.79TCr | |
-13.26% | 1.59TCr | |
-3.33% | 1.38TCr | |
-12.21% | 1.15TCr | |
-53.94% | 927.07Cr | |
+5.99% | 909.1Cr |
- Stock Market
- Equities
- A196170 Stock
- News ALTEOGEN Inc.
- ALTEOGEN Inc.’s Equity Buyback announced on December 12, 2016 has expired.